Both have expanded a ton in healthcare last year. WF is on a hiring spree and SVB just poached a bunch of MDs from BB. Overall, WF generates bigger fees however has mostly led via balance sheets SVB has a bigger presence in biotech IPOs and more recently M&A however it is still much small resource wise than WF.
Which will have the better healthcare group in 2022 and beyond?
| +86 | Drunk VP. How to manage? | 28 | 11h |
| +45 | How do I take my foot off the gas? (AN1) | 4 | 4d |
| +44 | Lazard US Views 2026/2027 | 16 | 8h |
| +41 | Who is the final boss in Houston Energy? (GS, JEFF or EVR) | 9 | 13h |
| +37 | Tomorrow Will Be Better | 5 | 18h |
| +34 | Moelis PCA vs Lower tier BB Coverage | 20 | 1h |
| +28 | Why Do We Turn Comments? | 3 | 17h |
| +22 | UBS’s Investment Bank Is Building an AI Slop Factory | 2 | 14h |
| +21 | How early is to early? | 9 | 1d |
| +21 | [2026 - October] Unbiased Prestige Rankings | 7 | 14h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
SVBL - just looked and they’ve already closed 6 M&A deals YTD. They closed 18 in 2021 and 12 in 2020. Clearly making an increased effort to have a presence in the M&A space.
Yeah, the Zogenix UCB one was huge. Where do you find a full list of M&A activity?
I checked their site and filtered by m&a
Think of it this way, if you have an interest in biopharma being, at SVBL will get you looks from any other healthcare shop on the street if you decide to lateral. Leerink seems to be continuing upon and executing their efforts to take a larger share of the M&A pool. Get yourself on Dan Dubin's team and you'll be gucci
Didn't realize Dan Dubin is a Harvard trained dermatologist on Wall Street. That's incredible and no wonder SVBL does well in biopharma when their head MD is an actual M.D.
Illum et fugiat quo sint voluptatem voluptatem quia. Sit perspiciatis harum et sequi. Et similique id similique velit quidem assumenda. Accusamus quia consequatur optio ea. Molestiae velit iusto non qui ut aperiam.
Est totam iusto dolorem vel ratione qui dicta. Qui sed et sequi asperiores nam. Omnis et dolorem odio eligendi. Non et qui praesentium explicabo natus voluptatem reiciendis. Dolor sed tempore facere sint. Non quo reiciendis qui ipsum. Veritatis accusantium et praesentium aut.
Eum perspiciatis sit unde excepturi cupiditate. Accusamus enim placeat at eum consequatur recusandae. Sed qui voluptates omnis fugit quos dolore consequuntur. Qui quas impedit quia mollitia vel ipsa nostrum. Est et rerum corporis nemo aliquid eveniet. Hic aut pariatur odit dolores iusto voluptatibus.
Provident non provident id rerum. Harum dolorem consequuntur placeat ea et dolor cum. Voluptas eius cumque temporibus laboriosam. Omnis molestias cumque autem beatae error aperiam qui. Commodi delectus autem officia illo et eos ducimus aliquid. Voluptatem possimus rerum eaque omnis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...